CVE-2023-43991
Source CVE Database V5
Not known to be exploited · CVSS 5.4 Medium.
Data as of 26 Oct 2026, 17:16 UTC
- EPSS
- 0.3% chance of exploitation in 30 days – higher than 33% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 24 Jan 2024
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
AI-suggested
Organizations should immediately audit and secure their channel access tokens by implementing strict access controls and rotating tokens regularly to limit exposure time. Monitoring and logging of token usage should be enhanced to detect anomalous notification activity. Developers should review the mini-app’s code and integration points to ensure tokens are not exposed in logs, URLs, or client-side storage. Applying the principle of least privilege to tokens and restricting their scope can reduce potential damage if leaked. User awareness campaigns can help mitigate the impact of malicious notifications by educating users to recognize suspicious messages. Finally, coordination with Line platform support and monitoring for vendor advisories or patches is essential for timely remediation.
Description
An issue in PRIMA CLINIC mini-app on Line v13.6.1 allows attackers to send crafted malicious notifications via leakage of the channel access token.